Yong Wang
35Patents
11h-index
110Co-inventors
78Inventor score
Filing activity: Jan 9, 2004 → Sep 25, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7579473B2 | c-Met modulators and methods of use | Emerging Cross-Sectional Technologies | 63 | Active |
| US8497284B2 | C-met modulators and method of use | Emerging Cross-Sectional Technologies | 50 | Active |
| US8067436B2 | c-Met modulators and methods of use | Emerging Cross-Sectional Technologies | 44 | Active |
| US7989622B2 | Phosphatidylinositol 3-kinase inhibitors and methods of their use | Emerging Cross-Sectional Technologies | 43 | Active |
| US8178532B2 | c-Met modulators and method of use | Emerging Cross-Sectional Technologies | 40 | Active |
| US7977345B2 | c-MET modulators and method of use | Chemistry; Metallurgy | 39 | Active |
| US9174947B2 | c-Met modulators and methods of use | Emerging Cross-Sectional Technologies | 38 | Active |
| US8476298B2 | c-Met modulators and method of use | Emerging Cross-Sectional Technologies | 37 | Active |
| US8748412B2 | Phenylalanine derivatives and their use as non-peptide GLP-1 receptor modulators | Chemistry; Metallurgy | 28 | Active |
| US7132533B2 | Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy | Chemistry; Metallurgy | 15 | Expired |
| US7462713B2 | Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy | Chemistry; Metallurgy | 13 | Active |
| US6967198B2 | Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy | Chemistry; Metallurgy | 11 | Expired |
| US8044062B2 | Substituted pyrido[2,3-d]pyrimidin-7(8H)-one inhibitors of phospatidylinositol 3-kinase alpha | Human Necessities | 8 | Active |
| US8222263B2 | Inhibitors of hedgehog pathway | Chemistry; Metallurgy | 3 | Active |
| US8026237B2 | Pyrrole derivatives as pharmaceutical agents | Chemistry; Metallurgy | 3 | Expired |
| US8076338B2 | Kinase modulators and methods of use | Human Necessities | 3 | Active |
| US10035790B2 | RORγ modulators | Chemistry; Metallurgy | 3 | Active |
| US7994172B2 | [1H-pyrazolo[3, 4-D]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-theoronine kinase modulators (P70s6k, Atk1 and Atk2) for the treatment of immunological, inflammatory and proliferative diseases | Human Necessities | 2 | Active |
| US11124482B2 | C-met modulators and methods of use | Emerging Cross-Sectional Technologies | 2 | Active |
| US11795201B2 | Brown fat-selective adipokines | Chemistry; Metallurgy | 1 | Active |
| US8889664B2 | Phosphatidylinositol 3-kinase inhibitors and methods of their use | Emerging Cross-Sectional Technologies | 1 | Active |
| US11708367B2 | Compounds for the treatment of kinase-dependent disorders | Chemistry; Metallurgy | 1 | Active |
| US11542259B2 | Compounds for the treatment of kinase-dependent disorders | Emerging Cross-Sectional Technologies | 1 | Active |
| US8754092B2 | Inhibitors of the hedgehog pathway | Chemistry; Metallurgy | 1 | Active |
| US11673897B2 | Compounds for the treatment of kinase-dependent disorders | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.